384 related articles for article (PubMed ID: 24517537)
1. Associations of nailfold capillary abnormalities and immunological markers in early Raynaud's phenomenon.
Schlager O; Kiener HP; Stein L; Hofkirchner J; Zehetmayer S; Ristl R; Perkmann T; Smolen JS; Koppensteiner R; Gschwandtner ME
Scand J Rheumatol; 2014; 43(3):226-33. PubMed ID: 24517537
[TBL] [Abstract][Full Text] [Related]
2. Associations between nailfold capillary aberrations and autoantibodies in children and adults with Raynaud's phenomenon.
Mueller M; Gschwandtner ME; Emminger W; Kiener H; Schnaubelt S; Giurgea GA; Ristl R; Perkmann T; Koppensteiner R; Schlager O
RMD Open; 2023 Mar; 9(1):. PubMed ID: 36972928
[TBL] [Abstract][Full Text] [Related]
3. Nailfold capillaroscopic findings in primary Sjögren's syndrome with and without Raynaud's phenomenon and/or positive anti-SSA/Ro and anti-SSB/La antibodies.
Corominas H; Ortiz-Santamaría V; Castellví I; Moreno M; Morlà R; Clavaguera T; Erra A; Martínez-Pardo S; Ordóñez S; Santo P; Reyner P; González MJ; Codina O; Gelman MS; Juanola-Roura X; Olivé A; Torrente-Segarra V;
Rheumatol Int; 2016 Mar; 36(3):365-9. PubMed ID: 26597492
[TBL] [Abstract][Full Text] [Related]
4. Scleroderma-like nailfold capillaroscopic abnormalities are associated with anti-U1-RNP antibodies and Raynaud's phenomenon in SLE patients.
Furtado RN; Pucinelli ML; Cristo VV; Andrade LE; Sato EI
Lupus; 2002; 11(1):35-41. PubMed ID: 11899953
[TBL] [Abstract][Full Text] [Related]
5. Nailfold capillary abnormalities are prevalent in sclerodermoid graft-versus-host disease and readily detected with dermatoscopy.
Akay BN; Sanli H; Topcuoglu P; Arat M; Akyol A
Br J Dermatol; 2010 May; 162(5):1076-82. PubMed ID: 20222922
[TBL] [Abstract][Full Text] [Related]
6. Relation of Nailfold Capillaries and Autoantibodies to Mortality in Patients With Raynaud Phenomenon.
Mueller M; Gschwandtner ME; Gamper J; Giurgea GA; Charwat-Resl S; Kiener HP; Smolen JS; Perkmann T; Koppensteiner R; Schlager O
Circulation; 2016 Feb; 133(5):509-17. PubMed ID: 26733605
[TBL] [Abstract][Full Text] [Related]
7. Early detection of connective tissue disease in patients with Raynaud's phenomenon.
Kallenberg CG
Rheum Dis Clin North Am; 1990 Feb; 16(1):11-30. PubMed ID: 2406802
[TBL] [Abstract][Full Text] [Related]
8. Reliability of widefield nailfold capillaroscopy and video capillaroscopy in the assessment of patients with Raynaud’s phenomenon.
Sekiyama JY; Camargo CZ; Eduardo L; Andrade C; Kayser C
Arthritis Care Res (Hoboken); 2013 Nov; 65(11):1853-61. PubMed ID: 23754794
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic factors in Raynaud's phenomenon: usefulness of antinuclear antibodies and of periungual capillaroscopy].
Passiu G; Sebastiani GD; Galeazzi M; Tuveri MA; Nicosia PM; Boirivant R
Medicina (Firenze); 1990; 10(4):405-7. PubMed ID: 2099984
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of nailfold capillaroscopy in patients with Raynaud's phenomenon.
Meli M; Gitzelmann G; Koppensteiner R; Amann-Vesti BR
Clin Rheumatol; 2006 Mar; 25(2):153-8. PubMed ID: 15951918
[TBL] [Abstract][Full Text] [Related]
11. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis.
Cutolo M; Pizzorni C; Tuccio M; Burroni A; Craviotto C; Basso M; Seriolo B; Sulli A
Rheumatology (Oxford); 2004 Jun; 43(6):719-26. PubMed ID: 15026581
[TBL] [Abstract][Full Text] [Related]
12. Assessment of nailfold capillaroscopy by x 30 digital epiluminescence (dermoscopy) in patients with Raynaud phenomenon.
Beltrán E; Toll A; Pros A; Carbonell J; Pujol RM
Br J Dermatol; 2007 May; 156(5):892-8. PubMed ID: 17388920
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.
Koenig M; Joyal F; Fritzler MJ; Roussin A; Abrahamowicz M; Boire G; Goulet JR; Rich E; Grodzicky T; Raymond Y; Senécal JL
Arthritis Rheum; 2008 Dec; 58(12):3902-12. PubMed ID: 19035499
[TBL] [Abstract][Full Text] [Related]
14. Prognostic model based on nailfold capillaroscopy for identifying Raynaud's phenomenon patients at high risk for the development of a scleroderma spectrum disorder: PRINCE (prognostic index for nailfold capillaroscopic examination).
Ingegnoli F; Boracchi P; Gualtierotti R; Lubatti C; Meani L; Zahalkova L; Zeni S; Fantini F
Arthritis Rheum; 2008 Jul; 58(7):2174-82. PubMed ID: 18576359
[TBL] [Abstract][Full Text] [Related]
15. Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis.
Minier T; Guiducci S; Bellando-Randone S; Bruni C; Lepri G; Czirják L; Distler O; Walker UA; Fransen J; Allanore Y; Denton C; Cutolo M; Tyndall A; Müller-Ladner U; Matucci-Cerinic M; ;
Ann Rheum Dis; 2014 Dec; 73(12):2087-93. PubMed ID: 23940211
[TBL] [Abstract][Full Text] [Related]
16. Differentiation between primary and secondary Raynaud's phenomenon: a prospective study comparing nailfold capillaroscopy using an ophthalmoscope or stereomicroscope.
Anders HJ; Sigl T; Schattenkirchner M
Ann Rheum Dis; 2001 Apr; 60(4):407-9. PubMed ID: 11247874
[TBL] [Abstract][Full Text] [Related]
17. Prospective nailfold capillaroscopy evaluation of Raynaud's phenomenon in children and adolescents.
Piotto DG; Hilário MO; Carvalho NS; Len CA; Andrade LE; Terreri MT
Acta Reumatol Port; 2013; 38(2):114-21. PubMed ID: 24141348
[TBL] [Abstract][Full Text] [Related]
18. Raynaud's phenomenon in undifferentiated connective tissue disease (UCTD).
De Angelis R; Cerioni A; Del Medico P; Blasetti P
Clin Rheumatol; 2005 Apr; 24(2):145-51. PubMed ID: 15351873
[TBL] [Abstract][Full Text] [Related]
19. [The diagnostic significance of nailfold video-capillaroscopy in systemic sclerosis].
Li LG; Zhang JL; Liu XH; Huang F
Zhonghua Nei Ke Za Zhi; 2012 May; 51(5):362-5. PubMed ID: 22883334
[TBL] [Abstract][Full Text] [Related]
20. Chronic inflammation predicts long-term mortality in patients with Raynaud's phenomenon.
Mueller M; Gschwandtner ME; Gamper J; Giurgea GA; Kiener HP; Perkmann T; Koppensteiner R; Schlager O
J Intern Med; 2018 Mar; 283(3):293-302. PubMed ID: 29068146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
